Management of pregnancies complicated by lethal fetal anomalies is addressed within an ethical framework that provides perinatal palliative care, parental support, and medical management without recourse to induced abortion. The chapter outlines clinical protocols for continuing care that respect fetal life while attending to maternal physical and psychological wellbeing through delivery and bereavement.
prenatal diagnosis of lethal birth defects, baby diagnosed with fatal abnormality, continuing pregnancy after terrible diagnosis, trisomy 18 support and palliative care, potter's syndrome pregnancy management, spina bifida detected on ultrasound, amniocentesis risks and fetal loss rate, chorionic villus sampling miscarriage risk, triple test false positive rate, down syndrome screening accuracy problems, perinatal hospice program, supporting families through lethal anomaly, moral alternative to selective abortion, carrying baby to term with fatal condition, cumulus oophorus ultrasound appearance, preconception genetic screening, non-directive counseling reproductive genetics, prenatal testing without abortion option, spiritual and psychological growth through loss, parenting dying baby before and after birth, physician support for continuing pregnancy, ethics of prenatal diagnosis, invasive testing embryo risk, early ultrasound gestational sac discrepancy, miscarriage prediction from sac measurement
Cite this article
Hilgers, T. W. (2004). Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 813-824.
Hilgers TW. Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:813-824.
Hilgers, T. W. "Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 813-824.
Hilgers TW2004The Medical and Surgical Practice of NaProTECHNOLOGY
Preconceptional optimization using CrMS cycle data establishes hormonal baselines, identifies correctable pathologies, and guides targeted supplementation before conception is attempted. Systematic pr...
Hilgers TW2004The Medical and Surgical Practice of NaProTECHNOLOGY
Recurrent spontaneous abortion is examined through a systematic NaProTECHNOLOGY diagnostic framework that includes hormonal, anatomical, immunological, and infectious etiologies identified via CrMS cy...
Hilgers TW2004The Medical and Surgical Practice of NaProTECHNOLOGY
Hilgers presents a refined classification of follicular and luteal phase deficiencies grounded in the integration of CrMS mucus pattern characteristics, cycle-phase-targeted estradiol and progesterone...
Hilgers TW et al.2004The Medical and Surgical Practice of NaProTECHNOLOGY
Family physicians are optimally positioned to introduce NaProTECHNOLOGY to patients presenting with infertility, irregular cycles, or recurrent pregnancy loss during routine primary care, enabling ear...